Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.
Cancer Treat Rev. 2011 May;37(3):169-77. doi: 10.1016/j.ctrv.2010.08.001. Epub 2010 Aug 25.
Cancer Treat Rev. 2011.
PMID: 20800360
Review.
Managing hyponatremia in lung cancer: latest evidence and clinical implications.
Fiordoliva I, Meletani T, Baleani MG, Rinaldi S, Savini A, Di Pietro Paolo M, Berardi R.
Fiordoliva I, et al. Among authors: di pietro paolo m.
Ther Adv Med Oncol. 2017 Nov;9(11):711-719. doi: 10.1177/1758834017736210. Epub 2017 Oct 28.
Ther Adv Med Oncol. 2017.
PMID: 29344107
Free PMC article.
Review.
Item in Clipboard
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type.
Maccaroni E, Lenci E, Agostinelli V, Cognigni V, Giampieri R, Mazzanti P, Di Pietro Paolo M, Bianchi F, Brugiati C, Belvederesi L, Pagliaretta S, Mandolesi A, Scarpelli M, Murrone A, Morgese F, Ballatore Z, Berardi R.
Maccaroni E, et al. Among authors: di pietro paolo m.
Explor Target Antitumor Ther. 2021;2(3):240-248. doi: 10.37349/etat.2021.00044. Epub 2021 Jun 28.
Explor Target Antitumor Ther. 2021.
PMID: 36046437
Free PMC article.
Item in Clipboard
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era.
Catania C, Piperno G, Russo A, Greco C, Agustoni F, Scotti V, Proto C, Sangalli C, Patani F, Santacaterina A, Di Pietro Paolo M, Agresti B, Filippi AR, Ramella S.
Catania C, et al. Among authors: di pietro paolo m.
Crit Rev Oncol Hematol. 2022 Jun;174:103684. doi: 10.1016/j.critrevonc.2022.103684. Epub 2022 Apr 21.
Crit Rev Oncol Hematol. 2022.
PMID: 35462031
Review.
Item in Clipboard
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group.
Catania C, Filippi AR, Sangalli C, Piperno G, Russano M, Greco C, Scotti V, Proto C, Bennati C, Di Pietro Paolo M, Platania A, Olmetto E, Agustoni F, Teodorani N, Agbaje V, Russo A.
Catania C, et al. Among authors: di pietro paolo m.
Crit Rev Oncol Hematol. 2023 Oct;190:104108. doi: 10.1016/j.critrevonc.2023.104108. Epub 2023 Aug 24.
Crit Rev Oncol Hematol. 2023.
PMID: 37633350
Review.
Item in Clipboard
Cite
Cite